GlassScriptPhysician profile
Srikanth Davuluri
NPI 1205034998
$20,023.33
in general payments reported to CMS, 2019-2025
19 companies · $457 in 2025
The $457 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $51.87 · 2021: $112 · 2022: $11K · 2023: $4,283 · 2024: $4,239 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,000 · Food and Beverage: $978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,000.00 |
| Food and Beverage | $978.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $18,243.57 | 2022-2024 | Da Vinci Sp, Da Vinci Surgical System |
| Genzyme Corporation | $402.31 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $295.78 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $257.57 | 2021-2024 | Dupixent |
| Glaxosmithkline, LLC. | $231.59 | 2019-2025 | Nucala |
| Astrazeneca Pharmaceuticals LP | $178.19 | 2019-2025 | Fasenra, Symbicort |
| Philips North America LLC | $163.06 | 2022-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Viatris Specialty LLC | $39.41 | 2025 | Yupelri |
| Janssen Pharmaceuticals, INC | $33.21 | 2021-2022 | |
| Mylan Specialty L.P. | $23.38 | 2022 | |
| Pulmonx Corporation | $21.61 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Amgen INC. | $20.00 | 2025 | Tezspire |
| Insmed, INC. | $19.07 | 2025 | Arikayce |
| Advanced Respiratory, INC | $18.00 | 2019 | |
| Medical Graphics Corporation | $16.54 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $16.13 | 2022 | |
| Jazz Pharmaceuticals INC. | $15.08 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.77 | 2019 | |
| Lilly USA, LLC | $14.06 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srikanth Davuluri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.